Log in
Article is 3.8 years old
Navigation
Generic medicines
BPJ Special Edition: Generics
Interview extracts:
Why use generic medicines? 0:35
Generic use in NZ compared to other countries 0:10
The steps in the tendering process for generics 3:10
Patient concerns about generics 2:09
Which medicines typically cause concerns? 2:16
How are generic medicines regulated in NZ? 1:13
Where are bioequivalence studies performed? 2:05
Ensuring the quality of bioequivalence studies 1:13
Does country of origin matter? 1:33
What is bioavailability? 1:14
What is bioequivalence? 1:33
How is bioequivalence established? 3:52
Bioequivalence acceptance criteria 2:27
What is the clinical relavance of bioequivalence? 0:25
The role of CARM 1:25
What patterns of reports are seen by CARM? 2:42
What happens with reports to CARM 4:07
PHARMACs role in monitoring brand change. 0:41
Dealing with patients concerns. 0:44
What are the main counseling points for patients? 1:14
How can health professionals help? 0:56
Generic medicines and generic brand change.
What is bioavailability?
Professor Stephen Duffull
